Investing.com UK - Financial Markets Worldwide
🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

Why Kiromic BioPharma Shares Are Trading Higher Today?

Published 07/07/2022, 15:14
Updated 07/07/2022, 16:10
© Reuters. Why Kiromic BioPharma Shares Are Trading Higher Today?
KRBP
-

  • Kiromic BioPharma Inc (NASDAQ: KRBP) has completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston.
  • The expanded facility located at Kiromic's headquarters is one of the conditions required for the Company to begin activating its cell therapy clinical trial for the Deltacel product candidate by the end of this year.
  • The completion also addresses a key component in the clinical hold communication the Company received from the FDA in June 2021.
  • Related: Kiromic BioPharma Prioritizes New Gamma Delta T-Cell Product Candidate.
  • "The on-time completion of our cGMP manufacturing facility is one of the conditions necessary to begin the activation of the Deltacel™ clinical trial by the end of this year," stated Pietro Bersani, Kiromic BioPharma's CEO.
  • Last month, Kiromic entered a Sponsored Research Agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies.
  • Price Action: KRBP shares are up 16.5% at $0.44 during the market session on the last check Thursday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.